Sign In
Buy DGX
$193.67
+0.510 (+0.264%)
At Close: Jun 03, 2026
10 defensive stocks that can also provide you with growth and dividends over the long term
01:34pm, Saturday, 13'th Aug 2022 MarketWatch
Professional money managers have a strong preference for one stock sector in particular, along with cash dividends.
ResMed (RMD) Q4 Earnings Beat Estimates, Gross Margin Up
07:34pm, Friday, 12'th Aug 2022 Zacks Investment Research
ResMed (RMD) posts better-than-expected Q4 results with continued strength in sleep and respiratory care devices sales performance.
STERIS (STE) Gains From Cantel Buyout, Supply Chain Issue Stays
02:05pm, Friday, 12'th Aug 2022 Zacks Investment Research
Revenue growth at STERIS' (STE) Applied Sterilization Technologies is driven by increased demand from medical device and biopharma customers.
Illumina stock tanks as gene-sequencing company misses expectations and issues bleak outlook
01:32am, Friday, 12'th Aug 2022 MarketWatch
Illumina Inc. shares sank 17% after hours Thursday after the gene-sequencing company swung to a loss in the second quarter, fell short of revenue expectations and revised its full-year outlook downwar
Haemonetics (HAE) Q1 Earnings Beat Estimates, Margins Up
06:10pm, Thursday, 11'th Aug 2022 Zacks Investment Research
Haemonetics (HAE) posts better-than-expected results in Q1 with robust contributions from the Hospital business.
Accuray (ARAY) Q4 Earnings Beat Estimates, Margins Down
05:13pm, Thursday, 11'th Aug 2022 Zacks Investment Research
Despite solid Product revenues, Accuray (ARAY) reports an overall soft Q4 performance.
Alcon (ALC) Q2 Earnings Surpass Estimates, Guidance Lowered
01:53pm, Thursday, 11'th Aug 2022 Zacks Investment Research
Alcon's (ALC) robust innovation pipeline is delivering solid results as evidenced by the successful launch of new ATIOL roles and SiHy contact lenses.
Omnicell (OMCL) Q2 Earnings Miss Estimates, Gross Margin Down
06:56pm, Wednesday, 10'th Aug 2022 Zacks Investment Research
Robust sales contribution from product and services segments drove Omnicell's (OMCL) Q2 top line.
Is Quest Diagnostics (DGX) Stock Undervalued Right Now?
01:40pm, Wednesday, 10'th Aug 2022 Zacks Investment Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
SmileDirectClub (SDC) Q2 Earnings Lag Estimates, Guidance Cut
01:38pm, Wednesday, 10'th Aug 2022 Zacks Investment Research
SmileDirectClub (SDC) witnesses a drop in both net and financing revenues on a year-over-year basis.
Masimo's (MASI) Q2 Earnings Surpass Estimates, Margins Down
01:37pm, Wednesday, 10'th Aug 2022 Zacks Investment Research
Masimo's (MASI) robust product shipments and strength in its healthcare business drive its Q2 sales.
Avanos (AVNS) Q2 Earnings Top Estimates, FY22 View Lowered
01:35pm, Wednesday, 10'th Aug 2022 Zacks Investment Research
Avanos's (AVNS) second-quarter 2022 results reflect strength in the Pain Management segment.
10 defensive stocks that can also provide you with growth and dividends over the long term
10:05am, Wednesday, 10'th Aug 2022
The S&P 500 Index has rallied 10% since June 22 from a deep decline, but there are different schools of thought about whether investors are out of the woods yet.
Insulet (PODD) Q2 Earnings Miss Estimates, '22 Sales View Up
04:08pm, Tuesday, 09'th Aug 2022 Zacks Investment Research
Insulet (PODD) posts better-than-expected revenues in Q2 with robust contributions from Total Omnipod.
Zimmer Biomet (ZBH) Sees Business Recovery, Global Growth
01:29pm, Tuesday, 09'th Aug 2022 Zacks Investment Research
Zimmer Biomet (ZBH) revenues ride on continued execution along with strong COVID recovery across most markets.
